CVS Health Corporation $CVS Shares Sold by Howard Capital Management Inc.

Howard Capital Management Inc. cut its position in shares of CVS Health Corporation (NYSE:CVS) by 45.7% during the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 8,003 shares of the pharmacy operator’s stock after selling 6,739 shares during the quarter. Howard Capital Management Inc.’s holdings in CVS Health were worth $603,000 as of its most recent filing with the SEC.

Other institutional investors have also modified their holdings of the company. National Pension Service boosted its stake in CVS Health by 3.1% during the third quarter. National Pension Service now owns 3,999,622 shares of the pharmacy operator’s stock valued at $301,532,000 after buying an additional 119,189 shares in the last quarter. Searle & CO. lifted its holdings in CVS Health by 0.9% in the 3rd quarter. Searle & CO. now owns 29,896 shares of the pharmacy operator’s stock valued at $2,254,000 after acquiring an additional 266 shares during the last quarter. Bryn Mawr Trust Advisors LLC bought a new position in shares of CVS Health during the 3rd quarter valued at about $266,000. Knights of Columbus Asset Advisors LLC acquired a new position in shares of CVS Health in the 3rd quarter worth approximately $296,000. Finally, Benedict Financial Advisors Inc. raised its holdings in shares of CVS Health by 1.1% in the 3rd quarter. Benedict Financial Advisors Inc. now owns 33,203 shares of the pharmacy operator’s stock worth $2,503,000 after purchasing an additional 365 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

Analyst Ratings Changes

Several research firms have issued reports on CVS. UBS Group restated an “outperform” rating on shares of CVS Health in a research report on Wednesday, December 10th. Bank of America reduced their price objective on CVS Health from $100.00 to $95.00 and set a “buy” rating for the company in a research note on Tuesday, January 27th. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of CVS Health in a research report on Wednesday, December 10th. Wall Street Zen lowered CVS Health from a “buy” rating to a “hold” rating in a research report on Saturday, November 1st. Finally, Wolfe Research boosted their price objective on CVS Health from $85.00 to $100.00 and gave the stock an “outperform” rating in a report on Monday, December 8th. Nineteen analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $94.82.

CVS Health Price Performance

NYSE CVS opened at $74.51 on Friday. The company has a 50 day simple moving average of $78.90 and a 200-day simple moving average of $75.16. CVS Health Corporation has a 52-week low of $53.36 and a 52-week high of $85.15. The firm has a market capitalization of $94.59 billion, a price-to-earnings ratio of 196.09, a price-to-earnings-growth ratio of 0.68 and a beta of 0.48. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.83 and a quick ratio of 0.63.

CVS Health (NYSE:CVS) last released its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.36 by $0.24. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The company had revenue of $102.87 billion during the quarter, compared to the consensus estimate of $98.85 billion. During the same quarter in the prior year, the firm earned $1.09 EPS. The company’s revenue was up 7.8% compared to the same quarter last year. Equities research analysts predict that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, February 2nd. Investors of record on Thursday, January 22nd will be given a dividend of $0.665 per share. The ex-dividend date of this dividend is Thursday, January 22nd. This represents a $2.66 dividend on an annualized basis and a yield of 3.6%. CVS Health’s dividend payout ratio (DPR) is presently 700.00%.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.